Gonzalo Fernández & team Santander
Santander’s six-strong squad under Gonzalo Fernández reclaims the No. 2 spot after spending last year in third place. “You can fully trust their unbiased recommendations,” insists one buy-side ally. The Mexico City–based crew added Genomma Lab Internacional to its top-picks list in January 2009 with a buy rating, at 9.57 Mexican pesos, telling clients that the small-cap developer of over-the-counter drugs was gaining market share and volume. Through July 2010 the stock gained an eye-popping 350.4 percent, to 43.10 pesos.
